(Q82153760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

T Kanno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

T Kamba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

T Yamasaki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

N Shibasaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R Saito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

N Terada

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Y Toda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Y Mikami

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

T Inoue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Kanematsu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

H Nishiyama

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

O Ogawa

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

E Nakamura

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

24 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

3098-3110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22020339%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2011.475

15 January 2020

exact match

0 references

cites work

Cancer and the chemokine network

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Renal-cell carcinoma--molecular pathways and therapies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Von Hippel-Lindau syndrome: molecular mechanisms of the disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

AP-1: a double-edged sword in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

pVHL: a multipurpose adaptor protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Chemokines as mediators of neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

31 March 2020

Focus on kidney cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Transcription factors control invasion: AP-1 the first among equals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

JunB can substitute for Jun in mouse development and cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Regulation and function of JunB in cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Resistance to targeted therapy in renal-cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

Von Hippel-Lindau disease and endocrine tumour susceptibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475

pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.475